Satisfaction Survey on Antipsychotic Formulations by Schizophrenia Patients in Japan-Reference-Cited by-同舟云学术

Satisfaction Survey on Antipsychotic Formulations by Schizophrenia Patients in Japan

Published:2021-11-30 Issue:4 Volume:19 Page:610-617
ISSN:1738-1088
Container-title:Clinical Psychopharmacology and Neuroscience
language:en
Short-container-title:Clin Psychopharmacol Neurosci

Author:

Hatano Masakazu¹²³^ORCID,Takeuchi Ippei³⁴^ORCID,Yamashita Kanade³^ORCID,Morita Aoi³^ORCID,Tozawa Kaori³⁵^ORCID,Sakakibara Takashi³⁶^ORCID,Hajitsu Genta³⁷^ORCID,Hanya Manako³^ORCID,Yamada Shigeki²^ORCID,Iwata Nakao¹^ORCID,Kamei Hiroyuki¹³^ORCID

Affiliation:

1. Departments of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan

2. Departments of Clinical Pharmacy, Fujita Health University School of Medicine, Toyoake, Japan

3. Office of Clinical Pharmacy Practice and Health Care Management, Faculty of Pharmacy, Meijo University, Nagoya, Japan

4. Department of Psychiatry, Okehazama Hospital, Toyoake, Japan

5. Department of Psychiatry, Kyowa Hospital, Obu, Japan

6. Department of Psychiatry, Holy Cross Hospital, Toki, Japan

7. Department of Psychiatry, Kamibayashikinen Hospital, Ichinomiya, Japan

Publisher

Korean College of Neuropsychopharmacology

Subject

Pharmacology (medical),Behavioral Neuroscience,Psychiatry and Mental health